News
Oxford Outcomes partners with the Office of Health Economics and the Department of Health
Oxford Outcomes has partnered with the Office of Health Economics, the University of Sheffield and the Department of Health, to undertake the initial valuation of the EQ-5D-5L, in a venture that will be completed over the next 6-9 months. Oxford Outcomes staff were key members of the team which developed the EQ-5D-5L prior to its release at ISPOR’s 2009 annual meeting. EQ-5D-5L is a new version of the EQ-5D, a standardised instrument to measure of health outcomes, applicable to a wide range of health conditions and treatments, providing a simple descriptive profile and a single index value for health status. Widely used by different decision making bodies, the EQ-5D is considered one of the most important PRO measures in the world. The partnership is already underway with three projects running from our Oxford offices and managed by Andrew Lloyd and Paul Swinburn. These projects will provide an interim value set for the EQ-5D-5L, the first will establish a cross walk or statistical mapping function and the other two will test new valuation methods prior to a major new international utilities study for EQ-5D-5L.Advisory board services launch in North America
Oxford Outcomes is introducing our advisory board services in Canada and the U.S. Having been available from the Oxford office since 2008, the services are now being expanded to all the North American offices. Drawing on our extensive network of clinicians, academic consultants, former reimbursement decision-makers and scientific and policy experts, we will organise an advisory panel designed to assist clients in devising the right strategies for their health care products. Our Advisory Board Services include meeting planning and logistics, participant recruitment, facilitation, reporting and meeting publications. Neil J. MacKinnon, PhD, FCSHP, will be working with the North American offices to provide advisory board services. Neil is the Associate Director for Research and Professor at the Dalhousie University College of Pharmacy and has extensive Advisory Board experience as both a panellist and facilitator.Oxford’s Webinar Programme is a continued success
In November 2009, the Oxford office launched a series of monthly training webinars aimed at clients and associates working in product development. Run by our most experienced members of staff the free webinars focus on regulatory and reimbursement approvals, and are open to all clients and associates within the pharmaceutical industry. Annabel Nixon, principal outcomes researcher, who coordinates the webinar series explains why it was launched, “We believe that providing free training of specific relevance to our clients’ day to day work will develop and strengthen our working relationships. Each webinar creates an opportunity for dialogue with clients through the questions and feedback following the session, allowing us to better understand clients’ needs and therefore produce work that is more relevant and specific than ever before.” Over the coming months the webinar programme will cover; PRO research for regulatory approvals and scientific dissemination, successful product reimbursement, and linguistic validation amongst other topics. Webinars run on a monthly basis, usually the second Thursday in every month at 3pm GMT/BST although this is subject to change. If you would like to find out more or be invited to participate please email louise.boxall@oxfordoutcomes.com.Chronic disease management pilot project in development
Oxford Outcomes, in partnership with the Asthma Society of Canada (ASC) and the Ontario Ministry of Health and Long Term care (MOHLTC), is designing a pilot project to demonstrate the effectiveness of medication reminders on improving medication adherence. The project will also investigate and demonstrate how medication reminder systems can be integrated into the existing framework for chronic disease management. The primary mechanism that will be investigated is a medication reminder program designed to enhance the management of chronic conditions. The pilot project will be focused on patients with asthma and will see the enrolment of asthma patients in three primary care settings to assess the effectiveness of proactive, telephony-based (automated voice and text messaging) adherence reminders and associated tele-services including: appointment reminders, medication record updates, and tele-counseling.If you have any questions or would like more information please email louise.boxall@oxfordoutcomes.com.